Yesenia Jiménez

ORCID: 0000-0001-7809-2062
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Glycosylation and Glycoproteins Research
  • Lymphoma Diagnosis and Treatment
  • RNA modifications and cancer

Hospital Universitario Fundación Jiménez Díaz
2020-2022

Universidad Autónoma de Madrid
2022

The SARS-CoV-2 infection has widely spread to become the greatest public health challenge date, COVID-19 pandemic. Different fatality rates among countries are probably due non-standardized records being carried out by local authorities. Spanish case-fatality rate is 11.22%, far higher than those reported in Asia or other European countries. A multicentre retrospective study of demographic, clinical, laboratory and immunological features 584 hospitalized patients their outcomes was...

10.1186/s12979-020-00194-w article EN cc-by Immunity & Ageing 2020-08-14

Abstract Background One hundred fifty million contagions, more than 3 deaths and little 1 year of COVID-19 have changed our lives health management systems forever. Ageing is known to be one the significant determinants for severity. Two main reasons underlie this: immunosenescence age correlation with comorbidities such as hypertension or dyslipidaemia. This study has two aims. The first obtain cut-off points laboratory parameters that can help us in clinical decision-making. second analyse...

10.1186/s12979-021-00237-w article EN cc-by Immunity & Ageing 2021-05-20

Activated B-cell (ABC) lymphoma, a distinct molecular entity within diffuse large lymphoma (DLBCL), remains highly incurable, showing worse response to standard immunochemotherapy. The discouraging results obtained in several clinical trials using proteasome inhibitors, tyrosine kinase or immunomodulators, lead an intense search for new, potentially druggable biomarkers DLBCL. In this study, we designed experimental strategy DLBCL discover high- and low-abundance RNA-seq-derived transcripts...

10.1080/10428194.2022.2056173 article EN Leukemia & lymphoma/Leukemia and lymphoma 2022-04-04

ABSTRACT Background SARS-CoV-2 infection has widely spread to the hugest public health challenge date, COVID-19 pandemic. Different fatality rates among countries are probably due non-standardized records being carried out by local authorities. Spanish case-fatality rate is 11.94%, far higher those reported in Asia or other European countries. A multicenter retrospective study was performed of demographic, clinical, laboratory and immunological features 574 hospitalized patients their...

10.1101/2020.05.13.20101345 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-05-16

Abstract Background: One hundred million of contagions, more than 2 deaths and less one year COVID-19 have changed our lives health management systems forever. Ageing is known to be the significant determinants for severity. Two main reasons underlie this: immunosenescence age correlation with comorbidities such as hypertension or dyslipidaemia. This study has two aims. The first obtain cut-off points laboratory parameters that can help us in clinical decision-making. second analyse effect...

10.21203/rs.3.rs-228480/v1 preprint EN cc-by Research Square (Research Square) 2021-03-10
Coming Soon ...